Chemoinformaics analysis of naphthalene-1,4-dione (Lapachol)
| Molecular Weight | 256.301 | nRot | 3 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 13 |
| Exact Molecular Weight | 256.11 | nRing | 2 |
| Solubility: LogS | -4.268 | nHRing | 0 |
| Solubility: LogP | 4.406 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 39.7947 |
| nHD | 0 | BPOL | 19.5233 |
| QED | 0.647 |
| Synth | 2.592 |
| Natural Product Likeliness | 1.193 |
| NR-PPAR-gamma | 0.962 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.006 |
| CACO-2 | -4.89 |
| MDCK | 0.0000241 |
| BBB | 0.095 |
| PPB | 0.990428 |
| VDSS | 0.406 |
| FU | 0.0274653 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.922 |
| CYP2c19-inh | 0.216 |
| CYP2c19-sub | 0.768 |
| CYP2c9-inh | 0.251 |
| CYP2c9-sub | 0.794 |
| CYP2d6-inh | 0.381 |
| CYP2d6-sub | 0.884 |
| CYP3a4-inh | 0.196 |
| CYP3a4-sub | 0.241 |
| CL | 5.567 |
| T12 | 0.697 |
| hERG | 0.025 |
| Ames | 0.336 |
| ROA | 0.909 |
| SkinSen | 0.954 |
| Carcinogencity | 0.752 |
| EI | 0.918 |
| Respiratory | 0.889 |
| NR-Aromatase | 0.849 |
| Antiviral | No |
| Prediction | 0.60663 |